Early Prenatal Screening Revolution: Fetal Fraction Amplification Enables Reliable cfDNA Testing From 7 Weeks of Gestation
This study demonstrates that fetal fraction amplification significantly improves cell-free DNA screening feasibility as early as 7 3/7 weeks gestation, maintaining high accuracy and low failure rates, potentially transforming early prenatal screening practices.